The FDA is taking steps to increase its scrutiny of efforts taken by medical device developers to limit cybersecurity vulnerabilities in their connected products, but may need to take extra steps, according to a newly released report from the US Dept. of Health and Human Services’ Office of Inspector General.
The report analyzed the FDA’s efforts to evaluate how secure devices are prior to approval, and found that the agency is taking a number of steps to do so, but could improve upon its current strategy.
